⚕ GalenOps CRO console
← 701 (USA)

701-1317

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 701 (USA) (Dr. Reyes) · consented 2014-05-22
Adverse events
9
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

mild assessed 2026-08-18

Mild APPLICATION SITE ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-06-23 (study day 33.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-06-23 (study day 33.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild APPLICATION SITE URTICARIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-06-23 (study day 33.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild CYST — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-05-13 (study day -9.0); relationship: NONE

mild assessed 2026-08-18

Mild DEPRESSED MOOD — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-07-04 (study day 44.0); relationship: POSSIBLE

moderate assessed 2026-08-18

Moderate DEPRESSED MOOD — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-07-04 (study day 44.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild DYSPHONIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-11-03 (study day 166.0); relationship: REMOTE

mild assessed 2026-08-18

Mild FATIGUE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-09-12 (study day 114.0); relationship: REMOTE

mild assessed 2026-08-18

Mild ONYCHOMYCOSIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-05-13 (study day -9.0); relationship: NONE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.